I have no idea if remdesivir works or not, but that is the problem with drugs in a shortage scenario like we're currently seeing. If there aren't enough of them, you're going to save them for the most critical patients. But those patients are the most likely to die anyway. That's why randomized controlled trials are so important. Data from a hospital that's not randomizing distribution of the drug is not really helpful.